Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Potassium Supplementation in Healthy Men
NCT02380157Phase 4Completed
- Sponsor
- Rigshospitalet Glostrup
- Start
- Mar 2015
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in hypertension (HTN) comparing Kaleorid with Placebo (2 arms). Primary endpoint: Change in Angiotensin II stimulated S-aldosterone at Day 28. Started Mar 2015; status: completed.
02
Drugs
potassium chloride
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT02380157.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02380157.